Physician profile
Mark S Wallis
NPI 1861489049
$10,589.42
in general payments reported to CMS, 2019-2025
39 companies · $2,790 in 2025
The $2,790 reported for 2025 was more than what 92% of Mohs-Micrographic Surgery providers received nationally (typical 2025 total: $462).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $796 · 2020: $591 · 2021: $1,047 · 2022: $1,613 · 2023: $1,616 · 2024: $2,136 · 2025: $2,790.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,329 · Education: $213.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,328.95 |
| Education | $213.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,334.93 | 2019-2025 | Rinvoq, Skyrizi |
| Genzyme Corporation | $934.57 | 2021-2025 | |
| Regeneron Healthcare Solutions, INC. | $866.18 | 2019-2025 | Dupixent, Libtayo |
| Sun Pharmaceutical Industries INC. | $839.77 | 2019-2025 | Winlevi, Ilumya |
| Janssen Biotech, INC. | $781.52 | 2020-2025 | Tremfya, Remicade, Simponi |
| Lilly USA, LLC | $777.05 | 2019-2025 | Taltz, Ebglyss, Olumiant |
| Novartis Pharmaceuticals Corporation | $691.04 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $521.84 | 2022-2025 | Sotyktu |
| Pfizer INC. | $372.00 | 2019-2025 | |
| Ucb, INC. | $347.38 | 2020-2025 | Bimzelx |
| Galderma Laboratories, L.P. | $338.45 | 2020-2025 | Nemluvio, Aklief |
| Amgen INC. | $250.27 | 2019-2024 | Otezla |
| Incyte Corporation | $202.81 | 2021-2025 | Opzelura |
| Leo Pharma INC. | $183.41 | 2021-2025 | Adbry |
| Strata Skin Sciences, INC. | $100.84 | 2024 | Xtrac |
Show all 38 companies
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Wallis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.